Immuno-Oncology and Other Therapeutic Areas

We do not plan to just beat cancer; we plan to outsmart it. Where past therapies have focused on killing the cancer at any cost, we are learning from the behavior of certain cancers that fool our bodies into thinking that they are benign tissue. By uncovering this behavior, not only are we able to target our treatment to the bad actors, we are developing treatments that use the body’s own immune system to fight them. As a result our treatments aim to eliminate cancer cells without damaging the healthy ones.
We currently have an ongoing Phase Ib clinical trial of CCX872 in patients with stage 3 or 4 pancreatic cancer.Learn More
In our preclinical research, we are evaluating the effect of combination therapy with chemokine receptor and check point inhibitors.Learn More